# OnCo record pierre-fenaux (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/pierre-fenaux/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "pierre-fenaux" ;
  schema:name "Pierre Fenaux"@en ;
  schema:description "Led AZA-001, which showed azacitidine extends survival in high-risk MDS and made hypomethylating agents standard."@en ;
  schema:url <https://onco.cc/people/pierre-fenaux/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Fenaux%20P%5BAuthor%5D%20azacitidine%20myelodysplastic> ;
  onco:tag "mds", "epigenetics", "france" ;
  schema:jobTitle "Professor of Hematology, Hôpital Saint-Louis, Université Paris Cité" ;
  onco:cancers <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:institutions <https://onco.cc/institutions/aphp-nord-cancer-institute/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-imerge-imetelstat-mds-lancet-2024/> ;
  schema:affiliation <https://onco.cc/institutions/aphp-nord-cancer-institute/> .